MS LifeLines Access Made Simple—recently expanded!
EMD Serono, Inc. and Pfizer Inc. are committed to helping people successfully start and stay on Rebif® (interferon beta-1a) as prescribed. Through MS LifeLines, a broad range of comprehensive assistance programs is offered to help meet the individual needs of affording Rebif for people living with relapsing MS.
One such program, MS LifeLines Access Made Simple, was recently expanded to offer more benefits to more people—including those presently taking Rebif.
An overview of the enhanced MS LifeLines Access Made Simple program:
The MS LifeLines Access Made Simple program is subject to change and discontinuation at any time.
This program is open to any of the following U.S. residents who have a relapsing form of MS:
- Newly starting Rebif.
- Restarting Rebif after 90 days.
- Presently taking Rebif therapy.
Some limitations are required by law:
- Patients residing in certain states, as well as patients covered by federal and state health care programs, are not eligible for assistance.
Learn more
To speak with an MS LifeLines Reimbursement Specialist about whether you may be eligible for MS LifeLines Access Made Simple
Indication
- Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS.
- Rebif is not approved for treatment of chronic progressive MS.
- Rebif is available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration pack by prescription only.
Important Safety Information
Before beginning treatment, patients should discuss with their doctor the potential benefits and risks associated with Rebif.
Let your doctor know:
- If you have a history of depression, seizures, liver disease, thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions to medications.
- About all medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Rebif and other medicines may affect each other, causing serious side effects.
- Before you take any new medicines.
Rebif is not recommended for women who are or plan to become pregnant.
Potential serious side effects of Rebif include:
- Depression and risk of suicide
- Liver problems
- Risk to pregnancy
- Injection-site problems
- Severe allergic reactions. Allergic reactions are rare and may be associated with difficulty in breathing and loss of consciousness, which require immediate medical attention.
The most common side effects with Rebif are:
- Injection-site reactions
- Flu-like symptoms (fever, chills, muscle aches, tiredness)
- Depression
- Abdominal pain
- Increased liver enzymes
- Blood cell count decreases
Let your doctor know if you have any of these symptoms or feel sad, tired, hot or cold, or experience hives, rashes, bruising, yellowing of the skin, or a change in body weight (gain or loss).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This information is not intended to replace discussions with your doctor. For additional information about Rebif, please consult the Prescribing Information and Medication Guide and talk to your doctor. You can also call toll-free 1-877-44-REBIF (1-877-447-3243). Rebif is available by prescription only.
MS LifeLines is an educational support service for people living with MS and their families. MS LifeLines and MS LifeLines Ambassadors are sponsored by EMD Serono, Inc. and Pfizer Inc. Speakers and MS LifeLines Ambassadors who participate in Talk MS or in live events are sponsored by EMD Serono, Inc. and Pfizer Inc. UNIQUELY [you] is a service mark of EMD Serono, Inc. or its affiliates. Rebif, Rebiject II and MS LifeLines are registered trademarks and the Rebif logo is a trademark of EMD Serono, Inc. or its affiliates.
Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of Rebif® (interferon beta-1a) in the US.
This information is intended only for residents of the United States.
Copyright © 2011 EMD Serono, Inc. All rights reserved.
EMD Serono, Inc., One Technology Place, Rockland, MA 02370
